Two Stage Study of Combination of Chemotherapy, SHR-1210 and/or Decitabine for Relapsed/Refractory PMBCLs

NCT03346642 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Primary Mediastinal Large B-cell Lymphoma

Interventions

DRUG: Decitabine
DRUG: GVD chemotherapy
DRUG: SHR-1210

Sponsor

Chinese PLA General Hospital